Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 82094-404
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 82094-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tianjin Kingyork Pharmaceuticals Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (125mg Vial Revised)
Image Description (1g Carton)
This is a package insert for Methylprednisolone Sodium Succinate, which is a medication for intravenous or intramuscular use. It is a multi-dose vial and does not contain diluent. It is stored at a controlled room temperature of 20°C to 25°C, and it should be reconstituted with 16 mL of Bacteriostatic Water for Injection containing benzyl alcohol. The solution must be used within 48 hours after mixing and should be protected from light. The dosage should be determined based on accompanying prescription information, and each vial when mixed contains methylprednisolone sodium succinate equivalent to 1 gram of methylprednisolone. The vial is manufactured by Tianjin Kingyork Pharmaceuticals in China.*
Image Description (1g Vial Revised)
This is a description of a medication called Methylprednisolone Sodium Succinate, which comes in a multi-dose vial containing 1g of powder for intramuscular or intravenous administration. The package does not contain a diluent, and the recommened diluent is bacterios afc water for injection with benzyl alcohol as a preservative. The medication should be stored at controlled room temperature, protected from light. After mixing, it can be used within 48 hours. The usual dosage should be determined by the prescribing information. The medication is made by Tiaofin Kingyork Pharmaceuticals O.L., located in Tianjin, China. The lot number and expiration date are also provided.*
Image Description (2g Carton)
methylPREDNISolone Sodium Succinate is a medication for intramuscular or intravenous use only, contained in a single dose vial. It does not contain diluent and must be reconstituted with 30mL of bacteriostatic water for injection with benzyl alcohol which is recommended as the diluent. This package is reserved for NDC barcodes and contains a non-varnished area for variable data such as Lot EXP SN and GTIN. This medication is manufactured by Tianjin Kingyork Pharmaceuticals Co. Ltd in China. The usual dosage must be seen with accompanying prescribing information.*
Image Description (2g Vial Revised)
This is a description of methylPREDNISolone Sodium Succinate for Injection, US. The package contains a single dose vial with 2g of the medication per vial, for intramuscular or intravenous use only. The package does not contain a diluent and it is recommended to use Bacteriostatic Water for injection as a diluent. Each 30.6 mL, when reconstituted, contains methylprednisolone sodium succinate equivalent to methylprednisolone, 2 grams. The medication should be stored at 20° to 25°C (68° to 77°F) in a controlled room temperature and protected from light. The solution should be used within 48 hours after mixing and should also be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and protected from light. The dosage should be as recommended in accompanying prescribing information.*
Image Description (40mg Carton)
Image Description (40mg Vial Revised)
Image Description (500mg Carton)
This is a description of a medication with the brand name Methylprednisolone Sodium Succinate. It is a vial of 500mg that is intended for intravenous or intramuscular use only. It does not come with a diluent, but Bacteriostatic Water for Injection with Benzyl Alcohol is recommended as a diluent. The diluent contains benzyl alcohol as a preservative. The package contains a multi-dose vial that should be stored between 20°C to 25°C (68°F to 77°F) and protected from light. Its dosage information can be found on the accompanying brochure. The chemical composition of each 8 mL mixed with 8 mL of diluent contains iprednisolone sodium, D S B o anhydrous, 6.4 mg and Eigboa:s?csndium phosphate, 6 mg. The medication is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd in Tianjin, China. The package includes a 2D data matrix.*
Image Description (500mg Vial Revised)
This is a medication with NDC number 82094-403-01. It is Methylprednisolone for injection, USP. It is a multilose vial and should be used intramuscularly or intravenously only. It does not contain a diluent and benzyl alcohol is recommended as preservative. The solution should be stored between 20 to 25°C and protected from light. Once reconstituted with bacteriostatic water for injection, the solution will have a concentration of 625 g per L. This medication is lyophilized in a container. Usual dosage is not available.*
Image Description (Logo)
Image Description (Msssf)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.